Market revenue in 2023 | USD 2.1 million |
Market revenue in 2030 | USD 3.6 million |
Growth rate | 8.3% (CAGR from 2023 to 2030) |
Largest segment | Human donor tissue-derived products |
Fastest growing segment | Human Donor Tissue-Derived Products |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human Donor Tissue-Derived Products, Acellular Animal-derived Products |
Key market players worldwide | 3M Co, Organogenesis Holdings Inc Class A, Integra Lifesciences Holdings Corp, Smith & Nephew PLC, MiMedx Group Inc, Essity AB Class B, Stryker Corp, Vericel Corp, Mallinckrodt PLC Ordinary Shares - New, Tissue Regenix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological skin substitutes market will help companies and investors design strategic landscapes.
Human donor tissue-derived products was the largest segment with a revenue share of 66.67% in 2023. Horizon Databook has segmented the South Africa biological skin substitutes market based on human donor tissue-derived products, acellular animal-derived products covering the revenue growth of each sub-segment from 2018 to 2030.
Various government initiatives, such as tax breaks, R&D credit, and the establishment of the South African Health Products Regulatory Authority (SAHPRA), are expected to increase foreign investments & collaborations in the country.
According to a report published by South African Medical Research Council, in 2022, medical device R&D in the country was very low; it was less than 1.0% compared to the total revenue of the industry in South Africa.
However, a range of incentives available for medical device innovators in the country is expected to support the market growth during the forecast period. In April 2021, the South African Medical Research Council, along with the Department of Science and Innovation (DSI) and Technology Innovation Agency, launched Technology Innovation Cluster Program (TICP) for diagnostics and medical devices to improve innovation in the medical device industry.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa biological skin substitutes market , including forecasts for subscribers. This country databook contains high-level insights into South Africa biological skin substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account